UNITED HEALTH PRODUCTS, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $0 | $37.5K | $59 | $643 | $4.9K |
| Cost of Revenue | — | — | — | $0 | $18.6K | $25 | $195 | $1.3K |
| Gross Profit | — | — | — | $0 | $18.9K | $34 | $448 | $3.6K |
| Gross Margin | — | — | — | — | 50.3% | 57.6% | 69.7% | 73.3% |
| Operating Expenses | ||||||||
| Research & Development | — | $269.9K | $355.9K | $598.8K | $624.6K | $237.5K | $245.2K | $666.4K |
| SG&A Expense | — | $2.0M | $1.7M | $1.8M | $2.2M | $29.6M | $14.6M | $5.4M |
| Operating Income | — | $-2.3M | $-2.0M | $-2.4M | $-2.8M | $-29.8M | $-14.8M | $-6.1M |
| Operating Margin | — | — | — | — | -7,472.1% | -50,509,550.8% | -2,309,277.0% | -123,688.1% |
| Interest Expense | — | $113.3K | $32.3K | $40.5K | $17.0K | $226.1K | $210.0K | $0 |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | — | $-2.7M | $-2.0M | $-2.6M | $-1.7M | $-30.5M | $-15.7M | $-6.6M |
| Net Margin | — | — | — | — | -4,500.0% | -51,778,276.3% | -2,443,452.6% | -134,002.3% |
| EPS (Basic) | — | — | — | — | — | — | $-0.09 | $-0.04 |
| EPS (Diluted) | — | $-0.01 | $-0.01 | $-0.01 | — | — | $-0.09 | $-0.04 |
| Shares Outstanding (Basic) | 258.7M | — | — | — | 230.9M | 228.7M | 189.4M | 178.1M |
| Shares Outstanding (Diluted) | 258.7M | 257.0M | 248.2M | 239.1M | 230.9M | 228.7M | 189.4M | 178.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |